An application of Ito's Lemma in population pharmacokinetics and pharmacodynamics

Pharmaceutical Research

Volumn 16, Issue 4, 1999, Pages 584-586

  Ramanathan, Murali ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Distribution; Ito's lemma; Log normal; Nonlinear pharmacodynamics; Stochastic

Indexed keywords

ARTICLE; CALCULATION; MATHEMATICAL MODEL; NONLINEAR SYSTEM; PHARMACODYNAMICS; PHARMACOEPIDEMIOLOGY; PHARMACOKINETICS; PRIORITY JOURNAL; STOCHASTIC MODEL;

ANALYSIS OF VARIANCE; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; MATHEMATICAL COMPUTING; NORMAL DISTRIBUTION; PHARMACOKINETICS; PHARMACOLOGY; STOCHASTIC PROCESSES;

EID: 0032950006     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011910800110     Document Type: Article

References (11)

1. 1. M. Rowland, L. B. Sheiner, and J.-L. Steimer. (1985). Variability in drug therapy: description, estimation, and control: a Sandoz workshop. xxi, 246.
2. 2. K. Ito. On stochastic differential equations. Memoirs, American Mathematical Society. 4:1-51 (1951).
3. 3. J. C. Hull. Options, futures, and other derivative securities, Prentice Hall, Englewood Cliffs, N.J., 1993.
4. 4. M. Gibaldi and D. Perrier. Pharmacokinetics, M. Dekker, New York, 1982.
5. 5. G. Levy. Impact of pharmacodynamic variability on drug delivery. Adv. Drug Del. Rev. 33:201-206 (1998).
6. 6. F. Black and M. Scholes. The pricing of options and corporate liabilities. J. Political Economy. 81:637-654 (1973).
7. 7. J. W. Lindeberg. Eine neue Herleitung des Exponentialgesetzes des Wahrscheilichkeitreschnung.Math. Zeitschrift. 15:221 (1922).
8. 8. P. Levy. Calcul des probabilites, Gauthiers-Villars, Paris, 1925.
9. 9. G. Levy. Bioavailability, clinical effectiveness, and the public interest. Pharmacology. 8:33-43 (1972).
10. 10. A. Hoffman. Pharmacodynamic aspects of sustained release preparations. Adv. Drug Del. Rev. 33:185-199 (1998).
11. 11. A. Hoffman and A. Goldberg. The relationship between receptor-effector unit heterogeneity and the shape of the concentration-effect profile: pharmacodynamic implications. J. Pharmacokin. Biopharm. 22:449-68 (1994).